The European Commission will take additional authorized motion in opposition to AstraZeneca over delayed shipments of its Covid-19 vaccines on Tuesday, an EU spokesperson mentioned in a press release on Monday.
Stefan De Keersmaecker, European Commission spokesperson for well being, meals security and transport, mentioned: “The second lawsuit concerns the merits of the case: on the basis of the provisions of the Advance Purchase Agreement [APA], the Commission requests the Court to adjudicate whether AstraZeneca has violated the APA.”
“Tomorrow, the introductory hearing will take place. The Court is expected to fix the deadlines for the submission of trial briefs and hearings,” he added.
On April 26, the EU introduced it was suing AstraZeneca over an alleged breach of its vaccine provide contract, a dramatic escalation of a months-long dispute over supply delays that hampered the rollout of photographs throughout the continent.
The 27 nations of the European Union had ordered 300 million doses of the Covid-19 vaccine from the British-Swedish drugmaker to be delivered by the tip of June, with an choice to buy an extra 100 million. But deliveries of the vaccine repeatedly fell quick, sparking a bitter public combat over the phrases of the contract.
In his assertion on Monday, De Keersmaecker mentioned that the primary case was an emergency injunction whereas the second is a lawsuit on the deserves of the case.
(*23*) that first lawsuit, he mentioned, “Given the urgent need of vaccine doses to continue the vaccination in the Member States, the Commission asked the court to require the company to deliver a sufficient number of doses. The court will only make a preliminary assessment of the case and assess whether there is an emergency to deliver doses. The hearing in this case will take place on 26 May.”
He mentioned the target of the fee is identical by means of each lawsuits, that’s, “ensuring, through legal actions, the delivery of a sufficient number of doses for the European citizens.”